Alan A Arslan

Summary

Affiliation: New York University School of Medicine
Country: USA

Publications

  1. pmc Defining the genomic signature of the parous breast
    Suraj Peri
    Breast Cancer Research Laboratory, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    BMC Med Genomics 5:46. 2012
  2. pmc Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan)
    Alan A Arslan
    Department of Obstetrics and Gynecology, New York University School of Medicine, 550 First Ave, TH 528, New York, NY 10016, USA
    Arch Intern Med 170:791-802. 2010
  3. pmc Circulating prolactin levels and risk of epithelial ovarian cancer
    Tess V Clendenen
    Department of Population Health, New York University School of Medicine, New York, NY, USA
    Cancer Causes Control 24:741-8. 2013
  4. pmc Factors associated with inflammation markers, a cross-sectional analysis
    Tess V Clendenen
    Department of Environmental Medicine, Division of Epidemiology, New York University School of Medicine, New York, NY, USA
    Cytokine 56:769-78. 2011
  5. doi request reprint Reproducibility of serum pituitary hormones in women
    Alan A Arslan
    Department of Obstetrics and Gynecology, New York University School of Medicine, 550 First Avenue, NBV 9E2, New York, NY 10016, USA
    Cancer Epidemiol Biomarkers Prev 17:1880-3. 2008
  6. pmc Premenopausal serum androgens and breast cancer risk: a nested case-control study
    Anne Zeleniuch-Jacquotte
    Department of Environmental Medicine, New York University School of Medicine, 650 First Avenue, New York, NY 10016, USA
    Breast Cancer Res 14:R32. 2012
  7. pmc Endogenous hormones and coronary heart disease in postmenopausal women
    Yu Chen
    Division of Epidemiology, Department of Environmental Medicine, New York University School of Medicine, New York, NY 10016 3240, United States
    Atherosclerosis 216:414-9. 2011
  8. pmc Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study
    Yian Gu
    Department of Environmental Medicine, New York University School of Medicine, 650 First Avenue, New York, NY 10016 3240, USA
    Cancer Causes Control 21:1323-33. 2010
  9. pmc Circulating inflammation markers and risk of epithelial ovarian cancer
    Tess V Clendenen
    Department of Environmental Medicine, Division of Epidemiology, New York University School of Medicine, New York, NY, USA
    Cancer Epidemiol Biomarkers Prev 20:799-810. 2011
  10. pmc Circulating 25-hydroxyvitamin D and risk of endometrial cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers
    Anne Zeleniuch-Jacquotte
    Department of Environmental Medicine and Cancer Institute, New York University, New York, 10016 3240, USA
    Am J Epidemiol 172:36-46. 2010

Detail Information

Publications21

  1. pmc Defining the genomic signature of the parous breast
    Suraj Peri
    Breast Cancer Research Laboratory, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    BMC Med Genomics 5:46. 2012
    ..This phenomenon is thought to be associated with the development and differentiation of the breast during pregnancy...
  2. pmc Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan)
    Alan A Arslan
    Department of Obstetrics and Gynecology, New York University School of Medicine, 550 First Ave, TH 528, New York, NY 10016, USA
    Arch Intern Med 170:791-802. 2010
    ..Obesity has been proposed as a risk factor for pancreatic cancer...
  3. pmc Circulating prolactin levels and risk of epithelial ovarian cancer
    Tess V Clendenen
    Department of Population Health, New York University School of Medicine, New York, NY, USA
    Cancer Causes Control 24:741-8. 2013
    ..Indirect evidence from experimental and epidemiological studies suggests that prolactin may be involved in ovarian cancer development. However, the relationship between circulating prolactin levels and risk of ovarian cancer is unknown...
  4. pmc Factors associated with inflammation markers, a cross-sectional analysis
    Tess V Clendenen
    Department of Environmental Medicine, Division of Epidemiology, New York University School of Medicine, New York, NY, USA
    Cytokine 56:769-78. 2011
    ..Our findings suggest that risk factors for chronic diseases (age, BMI, menopausal status, parity, NSAID use, family history of breast and ovarian cancer, and smoking) are associated with inflammation markers in healthy women...
  5. doi request reprint Reproducibility of serum pituitary hormones in women
    Alan A Arslan
    Department of Obstetrics and Gynecology, New York University School of Medicine, 550 First Avenue, NBV 9E2, New York, NY 10016, USA
    Cancer Epidemiol Biomarkers Prev 17:1880-3. 2008
    ....
  6. pmc Premenopausal serum androgens and breast cancer risk: a nested case-control study
    Anne Zeleniuch-Jacquotte
    Department of Environmental Medicine, New York University School of Medicine, 650 First Avenue, New York, NY 10016, USA
    Breast Cancer Res 14:R32. 2012
    ..Prospective epidemiologic studies have consistently shown that levels of circulating androgens in postmenopausal women are positively associated with breast cancer risk. However, data in premenopausal women are limited...
  7. pmc Endogenous hormones and coronary heart disease in postmenopausal women
    Yu Chen
    Division of Epidemiology, Department of Environmental Medicine, New York University School of Medicine, New York, NY 10016 3240, United States
    Atherosclerosis 216:414-9. 2011
    ..These findings suggest that circulating estradiol and SHBG are not associated with CHD risk in postmenopausal women beyond what can be explained by the variation in hypertension status, BMI, and cholesterol...
  8. pmc Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study
    Yian Gu
    Department of Environmental Medicine, New York University School of Medicine, 650 First Avenue, New York, NY 10016 3240, USA
    Cancer Causes Control 21:1323-33. 2010
    ..This study suggests that dysregulated cytokines may be involved in B-NHL development...
  9. pmc Circulating inflammation markers and risk of epithelial ovarian cancer
    Tess V Clendenen
    Department of Environmental Medicine, Division of Epidemiology, New York University School of Medicine, New York, NY, USA
    Cancer Epidemiol Biomarkers Prev 20:799-810. 2011
    ..The purpose of this study was to assess the association between circulating levels of inflammation mediators and subsequent risk of ovarian cancer...
  10. pmc Circulating 25-hydroxyvitamin D and risk of endometrial cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers
    Anne Zeleniuch-Jacquotte
    Department of Environmental Medicine and Cancer Institute, New York University, New York, 10016 3240, USA
    Am J Epidemiol 172:36-46. 2010
    ....
  11. pmc Genetic variants in hormone-related genes and risk of breast cancer
    Tess Clendenen
    Department of Population Health, New York University School of Medicine, New York, New York, United States of America
    PLoS ONE 8:e69367. 2013
    ..Our results suggest that these genetic variants do not have a strong effect on breast cancer risk. ..
  12. pmc Temporal reliability of cytokines and growth factors in EDTA plasma
    Tess V Clendenen
    Department of Environmental Medicine, New York University Langone Medical Center, New York, NY, USA
    BMC Res Notes 3:302. 2010
    ..Cytokines are involved in the development of chronic diseases, including cancer. It is important to evaluate the temporal reproducibility of cytokines in plasma prior to conducting epidemiologic studies utilizing these markers...
  13. pmc Reproducibility of serum cytokines and growth factors
    Yian Gu
    Department of Environmental Medicine, New York University School of Medicine, 650 First Avenue, New York, NY 10016, USA
    Cytokine 45:44-9. 2009
    ..Such an assumption is rarely tested although it may not be valid for all biomarkers. The objective of this study was to investigate the temporal reproducibility of a panel of cytokines and growth factors...
  14. doi request reprint Maternal and neonatal outcomes in early glucose tolerance testing in an obstetric population in New York city
    Orli Langer Most
    New York University Medical Center, New York, NY, USA
    J Perinat Med 37:114-7. 2009
    ..We sought to compare pregnancy outcomes in women who were diagnosed with GDM early in pregnancy with those diagnosed at the standard 24-28 weeks' gestation...
  15. pmc Characterization of a genomic signature of pregnancy identified in the breast
    Ilana Belitskaya-Levy
    Division of Biostatistics, Department of Environmental Medicine, New York University School of Medicine, New York, NY 10016, USA
    Cancer Prev Res (Phila) 4:1457-64. 2011
    ..The genomic signature of pregnancy could be used as an intermediate marker to assess potential chemopreventive interventions with hormones mimicking the effects of pregnancy for prevention of breast cancer...
  16. doi request reprint Parallel maternal and fetal immune activation by bacterial toxins in vitro
    Bruce K Young
    Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY 10016, USA
    J Perinat Med 40:73-6. 2011
    ..A maternal blood panel test might serve as a diagnostic screen for subclinical infection in patients at risk for preterm labor...
  17. doi request reprint The diagnosis, treatment, and follow-up of cesarean scar pregnancy
    Ilan E Timor-Tritsch
    Department of Obstetrics and Gynecology, NYU School of Medicine, New York, NY 10016, USA
    Am J Obstet Gynecol 207:44.e1-13. 2012
    ..The diagnosis and treatment of cesarean scar pregnancy (CSP) is challenging. The objective of this study was to evaluate the diagnostic method, treatments, and long-term follow-up of CSP...
  18. doi request reprint Atypical ezrin localization as a marker of locally advanced breast cancer
    Alan A Arslan
    Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY 10016, USA
    Breast Cancer Res Treat 134:981-8. 2012
    ..The cytoplasmic relocalization of ezrin may therefore represent a novel marker for large malignant tumor size, reflecting the unique biology of LABC...
  19. pmc Postmenopausal levels of endogenous sex hormones and risk of colorectal cancer
    Tess V Clendenen
    Division of Epidemiology, Department of Environmental Medicine, New York University School of Medicine, 650 First Avenue, 5th Floor, New York, NY 10016 3240, USA
    Cancer Epidemiol Biomarkers Prev 18:275-81. 2009
    ..Our results suggest that endogenous estrone is associated with increased risk of colorectal cancer in postmenopausal women...
  20. doi request reprint Predictors of severe perineal lacerations in Chinese women
    Nadav Schwartz
    Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY, USA
    J Perinat Med 37:109-13. 2009
    ..We sought to test the hypothesis that this risk is related to body mass index (BMI) or to a relative fetal-maternal size disproportion as measured by the ratio of the newborn birthweight to maternal BMI (BW:BMI)...
  21. doi request reprint Debate preparation/participation: an active, effective learning tool
    Nikki Koklanaris
    Department of Obstetrics and Gynecology, New York University School of Medicine, New York, New York, USA
    Teach Learn Med 20:235-8. 2008
    ..Passive educational techniques (such as lectures) are thought to be less productive than active learning...